Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy.

Yonsei Med J · 2020 · PMC7393290 · PMID 32734728

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

marginally significantp =0.051so close (0.05 < p ≤ 0.1)

Delayed ADT at PSA ≥2 ng/mL was an independent prognosticator of cancer-specific mortality ( p =0.047), and a marginally significant prognosticator of progression to CRPC ( p =0.051).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.